HANNAH MCCARTHY: Open Payments
NPI 1568928372 · SLINGERLANDS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 23 payments from 10 companies in 2025. Trend: 2023 $165 · 2024 $446 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 6 | $419 |
| Recor Medical Inc | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Biogen, Inc. | 4 | $94 |
| ABBVIE INC. | 3 | $66 |
| Astellas Pharma US Inc | 2 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| SHIELD THERAPEUTICS INC | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: VOQUEZNA, Paradise Ultrasound Renal Denervation System, INGREZZA, ZURZUVAE, VRAYLAR, Veozah, JOURNAVX, ACCRUFER.
Industry payments across NY — which companies pay providers there.
